Page 38 - P4403.14-V104 May OTC Magazine 2025 NI PRINT 10.04.25_Neat
P. 38

38  SKINCARE

















                       For Everyone’s   Sensitive Skin






                         A LEADING DERMATOLOGIST RECOMMENDED BRAND FOR SENSITIVE SKIN




                       ○  Included in over 850+ Galderma
                          clinical trials*                                       Save
                       ○  Clinically tested on more than                      15%         Off
                          37,000 subjects*                                      Trade

                       ○  Proven compatibility with
                          prescription treatments
                          8 PHASE studies with RX *
                       ○  4 products sold every minute**


                       *Nielsen L52wks ‘Unit Volume’ data up to 02/11/24.
                       **Galderma Data on File (RD.27.SPR.203715).


                                                                                           Buying     Trade
                                                      Product                         Size  Price/  RRP  Offer   POR    Pip Code
                                                                                                            %
                                                                                           Single      %
                                                      CETAPHIL
                                                                 CETAPHIL GENTLE SKIN CLEANSER     236ML  £5.82  £10.35  15%  33%  3660859
                                                                  CETAPHIL MOISTURISING LOTION  236ML  £5.82  £10.35  15%  33%  3661113






































                                                                                                                 11/04/2025   09:25:19
         P4403.14-V104 May OTC Magazine 2025 NI.indd   38                                                        11/04/2025   09:25:19
         P4403.14-V104 May OTC Magazine 2025 NI.indd   38
   33   34   35   36   37   38   39   40   41   42   43